340 related articles for article (PubMed ID: 27863423)
1. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
2. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cells promote triple-negative breast cancer cell metastasis
Zhang W; Xu J; Fang H; Tang L; Chen W; Sun Q; Zhang Q; Yang F; Sun Z; Cao L; Wang Y; Guan X
FASEB J; 2018 Jan; 32(1):276-288. PubMed ID: 28899878
[TBL] [Abstract][Full Text] [Related]
4. The potential to target CCL5/CCR5 in breast cancer.
Velasco-Velázquez M; Xolalpa W; Pestell RG
Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.
Tang S; Xiang T; Huang S; Zhou J; Wang Z; Xie R; Long H; Zhu B
Cancer Lett; 2016 Jun; 376(1):137-47. PubMed ID: 27033454
[TBL] [Abstract][Full Text] [Related]
6. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of the interaction between cancer cell-derived chemokine, CCL4, and intra-bone CCR5-expressing fibroblasts in breast cancer bone metastasis.
Sasaki S; Baba T; Nishimura T; Hayakawa Y; Hashimoto S; Gotoh N; Mukaida N
Cancer Lett; 2016 Aug; 378(1):23-32. PubMed ID: 27177471
[TBL] [Abstract][Full Text] [Related]
8. Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing.
Ishida Y; Kimura A; Kuninaka Y; Inui M; Matsushima K; Mukaida N; Kondo T
J Clin Invest; 2012 Feb; 122(2):711-21. PubMed ID: 22214846
[TBL] [Abstract][Full Text] [Related]
9. CCR5 antagonist blocks metastasis of basal breast cancer cells.
Velasco-Velázquez M; Jiao X; De La Fuente M; Pestell TG; Ertel A; Lisanti MP; Pestell RG
Cancer Res; 2012 Aug; 72(15):3839-50. PubMed ID: 22637726
[TBL] [Abstract][Full Text] [Related]
10. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.
Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC
Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461
[TBL] [Abstract][Full Text] [Related]
11. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.
Gao D; Cazares LH; Fish EN
BMC Cancer; 2017 Dec; 17(1):834. PubMed ID: 29216863
[TBL] [Abstract][Full Text] [Related]
12. CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.
Gao D; Rahbar R; Fish EN
Open Biol; 2016 Jun; 6(6):. PubMed ID: 27335323
[TBL] [Abstract][Full Text] [Related]
13. RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.
Datar I; Qiu X; Ma HZ; Yeung M; Aras S; de la Serna I; Al-Mulla F; Thiery JP; Trumbly R; Fan X; Cui H; Yeung KC
Oncotarget; 2015 Nov; 6(36):39050-61. PubMed ID: 26375811
[TBL] [Abstract][Full Text] [Related]
14. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
[TBL] [Abstract][Full Text] [Related]
15. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
Murooka TT; Rahbar R; Fish EN
Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
[TBL] [Abstract][Full Text] [Related]
16. CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1.
Singh S; Bruder-Nascimento A; Belin de Chantemele EJ; Bruder-Nascimento T
Biochem Pharmacol; 2022 Jan; 195():114859. PubMed ID: 34843718
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
Aldinucci D; Casagrande N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
[TBL] [Abstract][Full Text] [Related]
18. The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma.
Shen Z; Li T; Chen D; Jia S; Yang X; Liang L; Chai J; Cheng X; Yang X; Sun M
Oncol Rep; 2014 Feb; 31(2):800-6. PubMed ID: 24337063
[TBL] [Abstract][Full Text] [Related]
19. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.
Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L
Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870
[TBL] [Abstract][Full Text] [Related]
20. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]